Coronary Angiography Devices Market Report 2026

Coronary Angiography Devices Market Overview

• Coronary Angiography Devices market size has reached to $10.03 billion in 2025 • Expected to grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Rising Prevalence of Vascular Heart Diseases Drives Growth in Coronary Angiography Devices Market • Market Trend: Technological Innovations Driving Precision And Patient Outcomes In Interventional Cardiology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Coronary Angiography Devices Market?

Coronary angiography devices refer to medical instruments and systems used to visualize the coronary arteries, which supply blood to the heart. These devices are used in diagnostic procedures to detect blockages, narrowing, or other abnormalities in the coronary arteries. The process involves injecting a contrast dye into the coronary arteries, followed by imaging using X-rays to create detailed pictures of the blood vessels. The main types of products in the coronary angiography devices market are angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCDs), angiography balloons, angiography guidewires, and angiography accessories. Angiography systems are complex imaging setups that allow doctors to visualize blood vessels in real-time using X-rays. These devices utilize various technologies, including X-ray angiography, computed tomography angiography (CTA), magnetic resonance angiography, and others, to address indications like coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure, and others. They are applied in both diagnostics and therapeutics, serving end-users such as hospitals and clinics, diagnostic and imaging centers, and research institutes.

What Is The Coronary Angiography Devices Market Growth Forecast?

The coronary angiography devices market size is expected to see strong growth in the next few years. It will grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for early and accurate coronary diagnostics, expansion of interventional cardiology centers, rising adoption of image-guided cardiac procedures, growing focus on preventive cardiology care. Major trends in the forecast period include rising adoption of minimally invasive coronary diagnostic procedures, increasing use of advanced imaging systems in cardiac diagnostics, growing demand for high-precision coronary visualization, expansion of angiography use in early cardiac disease detection, increasing integration of diagnostic and therapeutic angiography workflows.

Global Coronary Angiography Devices Market Segmentation

1) By Product Type: Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires, Angiography Accessories 2) By Technology: X-Ray Angiography, Computed Tomography Angiography (CTA), Magnetic Resonance Angiography, Other Technologies 3) By Indication: Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Other Indications 4) By Application: Diagnostics, Therapeutics 5) By End-User: Hospital And Clinics, Diagnostic And Imaging Centers, Research Institutes Subsegments: 1) By Angiography Systems: X-Ray Angiography Systems, 3D Or 4D Angiography Systems, Digital Subtraction Angiography (DSA) Systems 2) By Angiography Catheters: Diagnostic Catheters, Therapeutic Catheters, Over-The-Wire (OTW) Catheters, Rapid Exchange (RX) Catheters 3) By Angiography Contrast Media: Iodinated Contrast Media, Non-Iodinated Contrast Media 4) By Vascular Closure Devices (VCDs): Mechanical VCDs, Passive Hemostasis VCDs, Active Hemostasis VCDs 5) By Angiography Balloons: High-Pressure Balloons, Low-Pressure Balloons, Drug-Eluting Balloons 6) By Angiography Guidewires: Standard Guidewires, Supportive Guidewires, Steerable Guidewires 7) By Angiography Accessories: Introducer Sheaths, Inflation Devices, Syringes And Needles, Guidewire Support Systems

What Is The Driver Of The Coronary Angiography Devices Market?

The increasing prevalence of vascular heart diseases is expected to propel the growth of coronary angiography devices market going forward. Vascular heart diseases encompass a group of conditions affecting the blood vessels supplying the heart or within the heart itself. The increasing prevalence of vascular heart diseases is caused due to changes in lifestyle habits such as diet and physical activity, an aging population, and the rising incidence of conditions such as diabetes and hypertension. Coronary angiography devices help diagnose and evaluate vascular heart diseases by providing detailed images of the coronary arteries, enabling precise identification of blockages, narrowing, and other abnormalities that can guide treatment decisions.For instance, in October 2024, according to the Centers for Disease Control and Prevention, is a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths. Therefore, the increasing prevalence of vascular heart diseases is driving the coronary angiography devices industry.

Key Players In The Global Coronary Angiography Devices Market

Major companies operating in the coronary angiography devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., Alvimedica

Global Coronary Angiography Devices Market Trends and Insights

Major companies operating in the coronary angiography devices market are focusing on developing technological advancements such as next-generation drug-eluting stents to enhance procedural precision, patient outcomes, and long-term cardiovascular care. Next-generation drug-eluting stents are advanced devices designed with improved scaffolding, drug coatings, and deliverability to reduce restenosis and optimize arterial healing. For instance, in May 2024, Abbott Laboratories, a US-based medical devices company, launched its XIENCE Sierra stent in India. The stent offers cardiologists enhanced flexibility, precise deployment, and improved safety, aiming to expand treatment options and elevate the standard of care in coronary artery disease management. By integrating cutting-edge design and clinical insights, this launch supports better procedural efficiency and patient-centric outcomes in interventional cardiology, while reinforcing Abbott’s commitment to innovation and advancing cardiovascular health globally.

What Are Latest Mergers And Acquisitions In The Coronary Angiography Devices Market?

In April 2023, Abbott a US-based medical device company acquired Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition is part of Abbott's strategy to expand its portfolio in the cardiovascular market, particularly in interventional therapies aimed at treating peripheral and coronary artery diseases. By integrating Cardiovascular Systems’ innovative technology and expertise, Abbott aims to enhance its capabilities and offerings in cardiovascular care. Cardiovascular Systems, Inc. is a US-based develops and sells products for treating coronary and peripheral vascular disease.

Regional Outlook

North America was the largest region in the coronary angiography devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Coronary Angiography Devices Market?

The coronary angiography devices market consists of revenues earned by entities by providing services such as imaging and diagnostic procedures, patient preparation and monitoring, and interventional treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary angiography devices market also includes sales of angiography systems, contrast media injectors, guidewires, and catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.